| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 10,241 | 10,243 | 10,466 | 10,369 | | Cost of Revenue | 1,625 | 1,661 | 1,734 | 1,566 | | | Gross Profit | 8,616 | 8,581 | 8,732 | 8,803 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,533 | 1,587 | 1,602 | 1,476 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,203 | 2,147 | 2,087 | 2,117 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,707) | 4,847 | 5,043 | 5,210 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 738 | 462 | (2,714) | (2,586) | | Earnings Before Interest And Taxes | (969) | 5,364 | 2,303 | 2,595 | | Interest Expense | 3,437 | 3,417 | 3,454 | 3,589 | | Income Before Tax | (4,406) | 1,947 | (1,151) | (994) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | (61) | (38) | (26) | (29) | | | | Net Income From Continuing Ops | 2,120 | 1,855 | (1,151) | (994) | | | Non-recurring Events | | Discontinued Operations | 34 | 34 | (245) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,154 | 1,889 | (1,396) | (994) | | Preferred Stock And Other Adjustments | (630) | (630) | (630) | (630) | | | Net Income Applicable To Common Shares | $1,524 | $1,259 | ($2,027) | ($1,624) |
|
0.02% Nasdaq 0.00%
Income Statement
